Healthcare -
Biotechnology - NASDAQ - US
$ 6.45
-4.02 %
$ 143 M
Market Cap
-2.96
P/E
INMB - OPERATING EXPENSES
Operating Expenses INMB - INmune Bio, Inc.
29.9 M
LAST VALUE
0.95%
2 YEAR CAGR
19.17%
5 YEAR CAGR
0.00%
10 YEAR CAGR